The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Essentially, all of these clinical studies involve either one or two psilocybin sessions. The dosages that were explored range from 0 milligrams. So placebo, if you will. 10 milligrams, in some cases, 25 milligrams, in some cases, 30 milligrams.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
It does that in the human brain at therapeutic doses of anywhere from 10 to 25, perhaps even 30 milligrams per session, one or two sessions.
As compared to say a 10-milligram dose given once, maybe twice in two separate sessions, or a 25 to 30 milligram dosage that's given once or twice.
So they receive pure psilocybin. Most of our studies are looking at where we we want a psychedelic effect are in the 20 to 30 migram range.